UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Symmetry Investments LP

Symmetry Investments LP boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,508 shares of the healthcare conglomerate’s stock after purchasing an additional 1,900 shares during the period. Symmetry Investments LP’s holdings in UnitedHealth Group were worth $5,861,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Aveo Capital Partners LLC grew its position in UnitedHealth Group by 23.8% during the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock valued at $1,139,000 after buying an additional 416 shares during the period. 9258 Wealth Management LLC increased its position in shares of UnitedHealth Group by 7.3% in the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after buying an additional 290 shares in the last quarter. Gryphon Financial Partners LLC lifted its position in shares of UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock valued at $3,275,000 after buying an additional 2,782 shares in the last quarter. TrinityPoint Wealth LLC lifted its holdings in UnitedHealth Group by 102.8% during the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after purchasing an additional 7,489 shares in the last quarter. Finally, Orion Portfolio Solutions LLC increased its stake in shares of UnitedHealth Group by 0.5% during the fourth quarter. Orion Portfolio Solutions LLC now owns 91,725 shares of the healthcare conglomerate’s stock worth $49,213,000 after purchasing an additional 462 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on UNH shares. Morgan Stanley boosted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. TD Cowen increased their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. UBS Group raised their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $575.00 on Friday. The stock has a 50-day simple moving average of $577.10 and a 200-day simple moving average of $520.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The stock has a market capitalization of $529.22 billion, a PE ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company earned $6.14 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.